电邮这篇文章 Development of approaches to enhancing adherence of patients withhuman immunodeficiency virus infection to antiretrovirustherapy
- 作者: Belyaeva VV1, Kravchenko AV1, Pokrovsky VV1
-
隶属关系:
- 期: 卷 78, 编号 11 (2003)
- 页面: 36-38
- 栏目: Editorial
- ##submission.dateSubmitted##: 09.04.2020
- ##submission.datePublished##: 15.11.2003
- URL: https://ter-arkhiv.ru/0040-3660/article/view/29696
- ID: 29696
如何引用文章
全文:
详细
Aim. To study approaches to enhancing adherence of HIV-infected patients receiving antiretrovirus
therapy.
Materials and methods. 25patients (including 3 females) aged 18 to 45 years receiving VAART (fortovasa + norvir + videx, and viramun) were examined. While treating the patients, group classes were
conducted to enhance their adherence to the therapy, followed by individual consultations in order to
consolidate the obtained effect. The adherence to the therapy was rated by the patients' self-reports.
Results. There was an increase in the activity and openness of those who attended group classes and
positive changes in their self-assessment. Approaches to enhancing adherence and a model of school
for HIV-infected individuals were developed.
Conclusion. It has been shown that a combination of patients' awareness of different HlV-infectionassociated problems with consulting allows treatment motivation to be increased.
therapy.
Materials and methods. 25patients (including 3 females) aged 18 to 45 years receiving VAART (fortovasa + norvir + videx, and viramun) were examined. While treating the patients, group classes were
conducted to enhance their adherence to the therapy, followed by individual consultations in order to
consolidate the obtained effect. The adherence to the therapy was rated by the patients' self-reports.
Results. There was an increase in the activity and openness of those who attended group classes and
positive changes in their self-assessment. Approaches to enhancing adherence and a model of school
for HIV-infected individuals were developed.
Conclusion. It has been shown that a combination of patients' awareness of different HlV-infectionassociated problems with consulting allows treatment motivation to be increased.
参考
- Moatti J. P., Spire В. Living with HIV/AIDS and adherence to antiretroviral treatments. In: Moatti J. P. et al., eds. AIDS in Europe: new challenges for social science. New York; 2000. 57-73.
- Weiss J. Attitudinal factors and adherence to protease inhibitor combination therapy. Ibid. 45-56.
- Patterson D. et al. How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMScaps. Jn: Program and abstracts of the 6th conference on retroviruses and opportunistic infections. Chicago; 1999. abstr. 092.
- Chesney M. A. et al. In: Chesney M. A. et al., eds. Advancing adherence: A clinical-patient collaboration. San Francisco; 2001.16
- Кравченко А. В., Рафальский В. В. Выбор антиинфекционных препаратов при ВИЧ-инфекции. В кн.: СтрачунскийЛ. С, Белоусов Ю. Б., Козлов С. Н. (ред.) М.: Боргес; 2002.307-317.
- Eldred L. J. et al. Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. J. Acquir. Immune Defic. Syndr. - 1998; 18: 117-125.
- Покровский В. В., Ермак Т. Н., Беляева В. В., Юрин О. Г. ВИЧ-инфекция: клиника, диагностика и лечение /Под общ. ред. В. В. Покровского. М.: Гэотар Медицина; 2000.
- Беляева В. В., Ручкина Е. В. Консультирование в системе реабилитации при ВИЧ-инфекции. Эпидемиол. и инфекц. бол. 2001; 1: 53-56.
- Chesney M. A. et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 2000; 12 (3): 255-266.
- Bartlett J. A. Addressing the Challenges of adherence. J. Acquir. Immune Defic. Syndr. 2002; 29 (suppl. 1): S2-S10.
补充文件
